Comments

Alzamend Neuro Stock Price, Quotes and Forecasts

Q: What sector and industry does Alzamend Neuro (ALZN) operate in?

Alzamend Neuro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ALZNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Alzamend Neuro (ALZN) Forecast

News Earnings Alzamend Neuro (ALZN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Alzamend Neuro Stock Price, Quotes and Forecasts | NASDAQ:ALZN | Benzinga

Explore Alzamend Neuro stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALZN.

Open	$2.97
Close	-
Volume / Avg.	195.13K / 1.55M
Day Range	$2.80 - $2.98
52 Wk Range	2.79 - 135.54
Market Cap	$2.10M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	99.34%
Days to Cover	1

Recent News

Alzamend Neuro (ALZN) Stock Surges On AL001 Phase II Trial Milestone

Alzamend Neuro shares surged after dosing the first patient in its AL001 Phase II trial. This novel lithium formulation aims for improved brain delivery and fewer side effects.

Henry Khederian

Crude Oil Falls Over 1%; Best Buy Reports Downbeat Results

Avi Kapoor

Nasdaq Gains Over 1%; Nvidia Posts Strong Revenue

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.97
Close	-
Volume / Avg.	195.13K / 1.55M
Day Range	$2.80 - $2.98
52 Wk Range	2.79 - 135.54
Market Cap	$2.10M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	99.34%
Days to Cover	1

About Alzamend Neuro Inc

Sector

Health Care

Industry

Biotechnology

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Alzamend Neuro (ALZN) stock?

You can purchase shares of Alzamend Neuro (NASDAQ:ALZN) through any online brokerage.

View our list of the best stock brokerages

Who are Alzamend Neuro (ALZN) competitors?

Other companies in Alzamend Neuro’s space includes: Plus Therapeutics (NASDAQ:PSTV), Entero Therapeutics (NASDAQ:ENTO), Oragenics (AMEX:OGEN), Qualigen Therapeutics (NASDAQ:QLGN) and NuCana (NASDAQ:NCNA).

What is the forecast, or price target, for Alzamend Neuro (ALZN) stock?

Alzamend Neuro has a consensus price target of $10.75.

What is the current price for Alzamend Neuro (ALZN)?

The stock price for Alzamend Neuro (NASDAQ: ALZN) is $2.87 last updated June 25, 2025 at 3:02 PM EDT.

Does Alzamend Neuro (ALZN) pay a dividend?

There are no upcoming dividends for Alzamend Neuro.

When is Alzamend Neuro (NASDAQ:ALZN) reporting earnings?

Alzamend Neuro’s Q1 earnings are confirmed for Wednesday, September 10, 2025.

Is Alzamend Neuro (ALZN) going to split?

There is no upcoming split for Alzamend Neuro.

What sector and industry does Alzamend Neuro (ALZN) operate in?

Alzamend Neuro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.